VANGUARD GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for Fate Therapeutics Inc Common Stock (FATE)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
FATE
Shares outstanding
114,748,220 shares
Disclosed Ownership
8,766,764 shares
Ownership
7.6%
Form type
SCHEDULE 13G/A
Filing time
29 Jul 2025, 13:13:36 UTC
Date of event
30 Jun 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 7.6% 8,766,764 0 45,249 Ashley Grim Head of Global Fund Administration